Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Cardiotonic   Milrinone lactate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Corotrop Austria, Germany, Sweden, Switzerland
Corotrope Argentina, Belgium, Chile, Colombia, France, Greece, Hungary, Luxembourg, Netherlands, Poland, Portugal, Spain, Tunisia, Venezuela
Fisatrek Mexico
Milricor Argentina, Turkey
Milrinona Argentina, Chile, Colombia, Ecuador
Milrinone Canada, Iran, United States of America
Milron Chile
Milrox Colombia
Primacor Great Britain, Iran, Malaysia, Mexico, New Zealand, United States of America
Unacor Romania
Vilmir Mexico
Stability of mixtures   Injection   Stability of mixtures : Milrinone lactate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Insulin 0,8 UI/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Nitroprusside sodium 0,4 mg/ml
22°C-23°C
4 Hour
Protect from light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Nitroglycerin 0,4 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Dopamine hydrochloride 3,1 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Dobutamine hydrochloride 4 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Epinephrine hydrochloride 0,03 µg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Norepinephrine bitartrate 0,03 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Ranitidine hydrochloride 0,85 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Cimetidine hydrochloride 2,9 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Pancuronium bromide 0,46 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Atracurium besylate 0,5 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Diltiazem hydrochloride 0,5 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Bumetanide 0,12 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Theophylline 0,89 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Propofol 5,3 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Heparin sodium 59 UI/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Morphine sulfate 0,5 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Lorazepam 0,1 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Midazolam hydrochloride 0,5 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Fentanyl citrate 25 µg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Isoprenaline hydrochloride 3,7 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Vecuronium bromide 0,52 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Rocuronium bromide 1 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,1 mg/ml
Injection   Milrinone lactate   
Injection   Digoxin 125 µg/ml
22°C-23°C
4 Hour
Light 191
Level of evidence A
Glass Glucose 5% 0,35 mg/ml
Injection   Milrinone lactate   
Injection   Digoxin 50 µg/ml
22°C-23°C
4 Hour
Light 191
Level of evidence A
Glass Glucose 5% 0,35 mg/ml
Injection   Milrinone lactate   
Injection   Propranolol hydrochloride 0,3 mg/ml
22°C-23°C
4 Hour
Light 191
Level of evidence A
Glass Glucose 5% 0,1 mg/ml
Injection   Milrinone lactate   
Injection   Propranolol hydrochloride 0,5 mg/ml
22°C-23°C
4 Hour
Light 191
Level of evidence A
Glass Glucose 5% 0,175 mg/ml
Injection   Milrinone lactate   
Injection   Quinidine gluconate 5 mg/ml
22°C-23°C
4 Hour
Light 191
Level of evidence A
Glass Glucose 5% 0,2 mg/ml
Injection   Milrinone lactate   
Injection   Quinidine gluconate 10 mg/ml
22°C-23°C
4 Hour
Light 191
Level of evidence A
Glass Glucose 5% 0,35 mg/ml
Injection   Milrinone lactate   
Injection   Verapamil hydrochloride 1 mg/ml
22°C-23°C
4 Hour
Light 191
Level of evidence A
Glass Glucose 5% 0,1 mg/ml
Injection   Milrinone lactate   
Injection   Verapamil hydrochloride 1,25 mg/ml
22°C-23°C
4 Hour
Light 191
Level of evidence A
  Mentions Légales